| RS61730328 |
ZFP57
|
Health Risk |
Pathogenic |
Diabetes mellitus, transient neonatal |
| RS61730334 |
FGF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Holoprosencephaly sequence, Holoprosencephaly sequence |
| RS61730489 |
IGSF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial congenital nasolacrimal duct obstruction, Familial congenital nasolacrimal duct obstruction |
| RS61730509 |
ABCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 1, Progressive familial intrahepatic cholestasis type 3 |
| RS61730537 |
KMT2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS61730638 |
PMM2
|
Health Risk |
Conflicting classifications of pathogenicity |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS61730768 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Oto-palato-digital syndrome, type II |
| RS61730807 |
MYH8
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH8-related disorder, MYH8-related disorder |
| RS61730847 |
MMP20
|
Health Risk |
Conflicting classifications of pathogenicity |
Amelogenesis imperfecta hypomaturation type 2A2, Amelogenesis imperfecta hypomaturation type 2A2 |
| RS61730848 |
MMP20
|
Health Risk |
Conflicting classifications of pathogenicity |
Amelogenesis imperfecta hypomaturation type 2A2, MMP20-related disorder |
| RS61730849 |
MMP20
|
Health Risk |
Conflicting classifications of pathogenicity |
Amelogenesis imperfecta hypomaturation type 2A2, MMP20-related disorder |
| RS61730903 |
SLC7A9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystinuria, Hepatocellular carcinoma |
| RS61730919 |
CHMP1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61730987 |
NCOA6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61731011 |
DSPP
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness, autosomal dominant 39 |
| RS61731073 |
SLC22A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS61731102 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS61731112 |
TNR
|
Health Risk |
Conflicting classifications of pathogenicity |
Parkinson disease, Parkinson disease |
| RS61731136 |
SALL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Townes syndrome, SALL1-related disorder |
| RS61731146 |
ADORA1
|
Health Risk |
Conflicting classifications of pathogenicity |
ADORA1-related disorder, ADORA1-related disorder |
| RS61731186 |
GRM6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61731381 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1F, Inborn genetic diseases |
| RS61731387 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS61731407 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS61731412 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS61731477 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, TBC1D24-related disorder |
| RS61731478 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 65, Developmental and epileptic encephalopathy |
| RS61731589 |
P2RX5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61731628 |
PHKG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXc, Glycogen storage disease IXc |
| RS61731629 |
MYO3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 30, Autosomal recessive nonsyndromic hearing loss 30 |
| RS61731652 |
MYO3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 30, Inborn genetic diseases |
| RS61731667 |
DEPDC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial focal epilepsy with variable foci, Inborn genetic diseases |
| RS61731714 |
ERCC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian cancer, Xeroderma pigmentosum |
| RS61731735 |
CHAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS61731823 |
MUC5B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61731831 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS61731907 |
IGHMBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS61731910 |
LIG4
|
Health Risk |
Pathogenic |
DNA ligase IV deficiency, DNA ligase IV deficiency |
| RS61731921 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Cardiomyopathy |
| RS61731946 |
HOGA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS61731956 |
NR1H3
|
Health Risk |
Pathogenic |
Multiple sclerosis, Multiple sclerosis |
| RS61731973 |
ABCC6
|
Health Risk |
Pathogenic |
— |
| RS61731996 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS61732003 |
ADGRE2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61732021 |
HS6ST1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61732056 |
CAMK2A
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 53 |
| RS61732144 |
ACADS
|
Health Risk |
Pathogenic |
Deficiency of butyryl-CoA dehydrogenase, Inborn genetic diseases |
| RS61732159 |
PEX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, Zellweger spectrum disorders |
| RS61732167 |
DNAJC30
|
Health Risk |
Pathogenic/Likely pathogenic |
DNAJC30-associated disorder, Leber hereditary optic neuropathy |
| RS61732179 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
HMCN1-related disorder, Age related macular degeneration 1 |
| RS61732295 |
GJB3
|
Health Risk |
Conflicting classifications of pathogenicity |
GJB3-related disorder, GJB3-related disorder |
| RS61732424 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, Autoinflammatory syndrome |
| RS61732521 |
PLCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61732523 |
PLCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 3 |
| RS61732532 |
TGFBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, TGFBR2-related disorder |
| RS61732534 |
STARD9
|
Health Risk |
Conflicting classifications of pathogenicity |
STARD9-related disorder, STARD9-related disorder |
| RS61732584 |
NLRP7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hydatidiform mole, recurrent |
| RS61732609 |
CYB5R3
|
Health Risk |
Pathogenic |
METHEMOGLOBINEMIA, TYPE II |
| RS61732702 |
TMEM260
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, TMEM260-related disorder |
| RS61732728 |
ANO10
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive spinocerebellar ataxia 10, ANO10-related disorder |
| RS61732733 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS61732782 |
TP63
|
Health Risk |
Conflicting classifications of pathogenicity |
Orofacial cleft 8, TP63-Related Spectrum Disorders |
| RS61732846 |
EZH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Weaver syndrome, Weaver syndrome |
| RS61732874 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS61733104 |
GGCX
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin K-dependent clotting factors, combined deficiency of |
| RS61733105 |
GGCX
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin K-dependent clotting factors, combined deficiency of |
| RS61733140 |
MTTP
|
Health Risk |
Conflicting classifications of pathogenicity |
Abetalipoproteinaemia, MTTP-related disorder |
| RS61733203 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Inborn genetic diseases |
| RS61733248 |
SERPINH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 10, Osteogenesis imperfecta |
| RS61733287 |
ADAM8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61733318 |
ANGPT2
|
Health Risk |
Pathogenic |
Lymphatic malformation 10, Lymphatic malformation 10 |
| RS61733327 |
ASNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, ASNS-related disorder |
| RS61733344 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma/paraganglioma syndrome 5, Mitochondrial complex II deficiency |
| RS61733362 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 43, Retinitis pigmentosa |
| RS61733390 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
VCAN-related disorder, Inborn genetic diseases |
| RS61733406 |
MMP13
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondyloepimetaphyseal dysplasia, Missouri type |
| RS61733448 |
PRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4F |
| RS61733519 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, LOXHD1-related disorder |
| RS61733565 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12 |
| RS61733577 |
CCDC39
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 14 |
| RS61733590 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS61733615 |
CYP27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestanol storage disease, Cardiovascular phenotype |
| RS61733629 |
ABCB6
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyschromatosis universalis hereditaria 3, Microphthalmia |
| RS61733679 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Inborn genetic diseases |
| RS61733680 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, ATP7B-related disorder |
| RS61733683 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS61733857 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Congenital stationary night blindness autosomal dominant 2 |
| RS61733863 |
GRM6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61733901 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with I factor anomaly, CFI-related disorder |
| RS61733910 |
SLC5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital glucose-galactose malabsorption, Congenital glucose-galactose malabsorption |
| RS61733946 |
ADAMTSL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Geleophysic dysplasia 1, Geleophysic dysplasia 1 |
| RS61733968 |
CACNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 4, Cardiovascular phenotype |
| RS61733982 |
TBCK
|
Health Risk |
Conflicting classifications of pathogenicity |
TBCK-related disorder, TBCK-related disorder |
| RS61734125 |
OTOG
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 18B, Autosomal recessive nonsyndromic hearing loss 18B |
| RS61734163 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS61734178 |
FGD1
|
Health Risk |
Likely pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS61734214 |
OTOG
|
Health Risk |
Conflicting classifications of pathogenicity |
Meniere disease, Meniere disease |
| RS61734270 |
PTGIS
|
Health Risk |
Likely pathogenic |
Childhood-onset schizophrenia, Childhood-onset schizophrenia |
| RS61734296 |
VANGL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sacral defect with anterior meningocele, Neural tube defect |
| RS61734338 |
SLC19A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Megaloblastic anemia |